Securian Asset Management Inc. lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 2.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,601 shares of the company’s stock after selling 165 shares during the quarter. Securian Asset Management Inc.’s holdings in HealthEquity were worth $633,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC grew its stake in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the last quarter. UMB Bank n.a. grew its stake in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Lindbrook Capital LLC grew its stake in HealthEquity by 27.6% during the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after buying an additional 162 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its stake in HealthEquity by 50.7% during the 4th quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock worth $107,000 after buying an additional 375 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Analyst Upgrades and Downgrades
HQY has been the topic of a number of research reports. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 25th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $112.92.
HealthEquity Trading Up 3.7 %
Shares of HQY opened at $97.41 on Monday. The stock has a 50-day moving average price of $105.68 and a 200 day moving average price of $95.35. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a market capitalization of $8.44 billion, a P/E ratio of 89.37, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.
Insider Transactions at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.20% of the company’s stock.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Bank Stocks – Best Bank Stocks to Invest In
- How to Build the Ultimate Everything ETF Portfolio
- Earnings Per Share Calculator: How to Calculate EPS
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is a Death Cross in Stocks?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.